Trichobiolight: A new, effective protocol in the treatment of androgenetic alopecia and telogen effluvium
February 2021
in “Dermatologic Therapy”
TLDR
Trichobiolight effectively treats hair loss with 82.5% success.
Trichobiolight is a new treatment protocol that combines mesotherapy and LED light to treat hair loss diseases such as androgenetic alopecia and telogen effluvium. A study with 107 patients showed that it was effective in treating these conditions, with 82.5% of patients having excellent to good outcomes. Trichobiolight is a non-invasive treatment that uses light therapy to stimulate hair growth and improve scalp health. It has shown promising results in clinical studies for androgenetic alopecia and telogen effluvium.
View this study on onlinelibrary.wiley.com →
Cited in this study
research Comparative study between mesotherapy and topical 5% minoxidil by dermoscopic evaluation for androgenic alopecia in male: A randomized controlled trial
research Androgenetic alopecia: An update
Minoxidil and finasteride effectively treat hair loss.
research Androgenetic alopecia
Various treatments exist for hair loss, but more research is needed for better options.
research Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: photographic, morphometric and ultrustructural evaluation
Dutasteride-containing mesotherapy effectively treats female hair loss, improving density and thickness with minimal side effects.
research Evaluation of the effect of injection of dutasteride as mesotherapeutic tool in treatment of androgenetic alopecia in males
Dutasteride mesotherapy helps treat male hair loss but may harm sperm and sexual function.
research Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex
Common baldness, also known as Androgenetic Alopecia, is caused by a combination of genetic factors and hormones called androgens.